AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

New Insight! Non-Invasive Sample Collection for Infectious Disease Testing

  • Duration: 1.5 hours
  • Date:JUL.26.2022 7:00 a.m. - 08:30 a.m.
  • Level: Intermediate

Price: $0.00

Member Price: $0.00

Rating: Member Average

This program was originally presented on July 26, 2022, during the 2022 AACC Annual Scientific Meeting, held in Chicago, Il.

With your registration, you will have access to the recording on demand through October 31, 2023.


During the COVID-19 pandemic, there was an increased need for non-invasive, self-collection of samples for diagnostic testing for SARS-CoV-2 as well as at-home collection solutions for other infectious diseases, including detection of Human Papilloma Virus (HPV) that can cause cervical cancers and other STI infections. 

In this session, we’ll discuss the impact of the pandemic on using non-traditional sample types for diagnostic testing, including data on the benefits of utilizing saliva as a sample type for SARS-CoV-2 testing during a pandemic. We will also explore advances in utilizing first-void urine as a non-invasive, self-sampling method for detection of HPV.


This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, toxicologists, fellows, residents, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.


At the end of this activity, participants will be able to:

  • Understand the contributing factors of the COVID-19 pandemic that highlighted the critical need for non-invasive (at-home) self-collection of samples for diagnostic testing. 
  • Learn how utilizing saliva collection (in both adults and children) for SARS-Cov-2 testing enabled a clinical lab to support their community by providing non-invasive, self-collection of saliva samples for testing and variant monitoring. 
  • Explore the advances in clinical data supporting first-void urine as a non-invasive, (at-home) self-collection sampling method for detection of HPV.



Mara G. AspinallMara G. Aspinall, MBA
Managing Director
BlueStone Venture Partners
Tucson, AZ


Frank MiddletonFrank Middleton, PhD
Professor in the Departments of Neuroscience & Physiology, Psychiatry & Behavioral Sciences, and Biochemistry & Molecular Biology
SUNY Upstate Medical University
Syracuse, NY

Jennifer SmithJennifer S. Smith, PhD, MPH
Professor in the Department of Epidemiology
University of North Carolina Gillings School of Global Public Health
Chapel Hill, NC


The information presented for this webinar was developed by the speakers in partnership with DNA Genotek and Novosanis for an industry-sponsored educational workshop. The content does not reflect an official position of AACC.


This activity is not accredited for ACCENT continuing education credits.

Sponsored By

DNA Genotek Logo

Novosanis Logo